Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $55.92 USD
Change Today +0.44 / 0.79%
Volume 51.1K
GB On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

greatbatch inc (GB) Snapshot

Open
$55.39
Previous Close
$55.48
Day High
$56.06
Day Low
$55.23
52 Week High
03/25/15 - $56.82
52 Week Low
09/25/14 - $42.23
Market Cap
1.4B
Average Volume 10 Days
106.6K
EPS TTM
$2.49
Shares Outstanding
25.4M
EX-Date
--
P/E TM
22.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for GREATBATCH INC (GB)

Related News

No related news articles were found.

greatbatch inc (GB) Related Businessweek News

View More BusinessWeek News

greatbatch inc (GB) Details

Greatbatch, Inc. designs, manufactures, and sells medical devices and components for the cardiac, neuromodulation, orthopaedics, portable medical, vascular, energy, and clinical markets worldwide. It operates in two segments, Greatbatch Medical and QiG Group. The company offers cardiac and neuromodulation products, including batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, implantable stimulation leads, and enclosures used in implantable medical devices; and orthopaedics products, such as hip and shoulder joint reconstruction implants, bone plates and spinal devices, and instruments and delivery systems used in hip and knee replacement, trauma fixation, extremity, and spine surgeries. It also provides vascular products comprising off-the-shelf introducers, steerable sheaths, and components for catheters that deliver minimally invasive therapies for coronary and neurovascular disease, peripheral vascular disease, interventional radiology, vascular access, atrial fibrillation, and interventional cardiology, as well as products for medical imaging and drug and pharmaceutical delivery. In addition, Greatbatch, Inc. offers customized battery power and management systems, charging and docking stations, and power supplies; non-rechargeable and rechargeable battery solutions, which are used in the portable medical, energy, military, and environmental markets; and rechargeable battery packs, such as electronics, charging, and battery management systems that are used in critical and life-saving applications. Further, it provides implantable pulse generators, programmer systems, and patient wands; and neural interface technology, components, and systems. The company serves multi-national original equipment manufacturers, numerous scientists, hospitals, and universities, as well as research companies and institutes, and early stage medical device companies. Greatbatch, Inc. was founded in 1970 and is headquartered in Frisco, Texas.

3,690 Employees
Last Reported Date: 03/3/15
Founded in 1970

greatbatch inc (GB) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $616.3K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $366.1K
Executive Vice President of Global Operations
Total Annual Compensation: $328.3K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $242.9K
Compensation as of Fiscal Year 2013.

greatbatch inc (GB) Key Developments

Greatbatch, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended January 2, 2015; Provides Earnings Guidance for the Fiscal Year 2015

Greatbatch, Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended January 2, 2015. For the quarter, the company reported sales of $169,726,000 compared to $176,619,000 a year ago. Operating income was $17,408,000 compared to $12,863,000 a year ago. Income before provision for income taxes was $17,486,000 compared to $11,217,000 a year ago. Net income was $14,176,000 or $0.54 per diluted share compared to $ 9,781,000 or $0.38 per diluted share a year ago. Adjusted operating income was $22,655,000 compared to $19,407,000 a year ago. Adjusted Diluted EPS was $0.65 against $0.55 a year ago. Adjusted EBITDA was $31,996,000 against $28,715,000 a year ago. Cash flow from operating activities were $26.6 million compared to $40.7 million for the same period last year. The quarter over quarter decrease was a result of higher working capital balances, primarily due to the timing of collection on accounts receivable partially offset by a higher level of cash operating income. Capital expenditures were $8.8 million compared to prior year capital expenditures of $3.6 million respectively. For the year, the company reported sales of $687,787,000 compared to $663,945,000 a year ago. Operating income was $75,654,000 compared to $61,339,000 a year ago. Income before provision for income taxes was $76,579,000 compared to $48,838,000 a year ago. Net income was $55,458,000 or $2.14 per diluted share compared to $36,267,000 or $1.43 per diluted share a year ago. Adjusted operating income was $91,211,000 compared to $82,922,000 a year ago. Adjusted Diluted EPS was $2.42 against $2.10 a year ago. Adjusted EBITDA was $128,408,000 against $118,888,000 a year ago. Cash flow from operating activities were $81.3 million compared to $56.8 million for the same period last year. Capital expenditures were $24.8 million compared to prior year capital expenditures of $18.6 million respectively. For the fiscal year 2015, the company expects sales to be between $715 million and $730 million. GAAP Operating Income as a % of Sales is expected between 10.7% and 11.0%. Adjusted Operating Income as a % of Sales is expected between 13.7% and 14.0%. Capital Expenditures is expected between $35 and $45 million. GAAP effective tax rate is expected to be 25%. Adjusted effective tax rate is expected to be 26%. GAAP Diluted EPS is expected between $2.02 and $2.12. Adjusted Diluted EPS is expected between $2.61 and $2.71. Adjusted operating cash flows are expected to be between $80 million and $100 million.

Greatbatch, Inc. to Report Q4, 2014 Results on Feb 24, 2015

Greatbatch, Inc. announced that they will report Q4, 2014 results at 8:05 PM, GMT Standard Time on Feb 24, 2015

Greatbatch, Inc., Q4 2014 Earnings Call, Feb 24, 2015

Greatbatch, Inc., Q4 2014 Earnings Call, Feb 24, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GB:US $55.92 USD +0.44

GB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Analogic Corp $90.44 USD +0.57
Astronics Corp $72.07 USD +1.43
Newport Corp $18.92 USD -0.19
Saft Groupe SA €34.07 EUR +0.05
Universal Electronics Inc $56.24 USD +0.48
View Industry Companies
 

Industry Analysis

GB

Industry Average

Valuation GB Industry Range
Price/Earnings 26.2x
Price/Sales 2.0x
Price/Book 2.3x
Price/Cash Flow 25.6x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GREATBATCH INC, please visit www.greatbatch.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.